SCHEMBL256090

SCHEMBL256090

CCc1[nH]cnc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12844533 0.83
SCHEMBL9435912 0.78
SCHEMBL1509606 0.78
SCHEMBL9938808 0.78
SCHEMBL1005836 0.78
SCHEMBL7999506 0.78
SCHEMBL6850308 0.78 HRH3 (0.42)
Hydrochloric Acid SCHEMBL9435572 0.76
Hydrochloric Acid SCHEMBL1636691 0.76
Hydrochloric Acid SCHEMBL7447885 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218597-A1 SUBSTITUTED PYRIDINES AND METHODS OF USE THERAVANCE BIOPHARMA R&D IP LLC (US) 2023-07-13 US disclosed
EP-3865477-B1 CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2023-07-12 EP disclosed
EP-4194449-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Meiyue Biotech Development Co., Ltd. (CN) 2023-06-14 EP disclosed
US-11590116-B2 Substituted pyridines and methods of use THERAVANCE BIOPHARMA R&D IP, LLC (US) 2023-02-28 US disclosed
US-11180474-B2 Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2021-11-23 US disclosed
WO-2021113669-A1 CANNABINOIDS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. (US) 2021-06-10 WO disclosed
US-20210154179-A1 SUBSTITUTED PYRIDINES AND METHODS OF USE THERAVANCE BIOPHARMA R&D IP, LLC (US) 2021-05-27 US disclosed
US-10995091-B2 CXCR4 receptor antagonists PROXIMAGEN LLC (US) 2021-05-04 US disclosed
EP-3490983-B1 DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-02-17 EP disclosed
US-10870660-B2 Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect SHIONOGI & CO., LTD. (JP) 2020-12-22 US disclosed
US-7605134-B2 Pesticides MERIAL LIMITED (US) 2009-10-20 US disclosed
US-20090227797-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-09-10 US disclosed
US-20090121202-A1 C.I. Pigment Blue 80-Based Blue Dye CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2009-05-14 US disclosed
WO-2008082484-A1 4,5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS SCHERING CORPORATION (US) 2008-07-10 WO disclosed
US-20080153778-A1 N-aryl pyrazole compounds, compositions, and methods for their use AMGEN INC. 2008-06-26 US disclosed
US-20080153778-A1 N-aryl pyrazole compounds, compositions, and methods for their use AMGEN INC. 2008-06-26 US disclosed
US-7387670-B2 Pigment preparations based on phthalocyanine pigments CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2008-06-17 US disclosed
WO-2008045484-A1 N-ARYL PYRAZOLE COMPOUNDS FOR USE AGAINST DIABETES AMGEN INC. (US) 2008-04-17 WO disclosed
US-20070186815-A1 Pigment preparations based on phthalocyanine pigments CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2007-08-16 US disclosed
US-20070186804-A1 Violet colorant for colour filters, inks for ink-jet electrophotographic toners and developers and e-inks CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2007-08-16 US disclosed